A Memphis hospital confirmed that it did, indeed, perform liver transplant surgery on Apple CEO Steve Jobs. Apple, has yet to mutter a word on the topic.
Methodist Hospital in Memphis posted a statement to its website confirming news first reported by the Wall Street Journal (siting unnamed sources) last Friday.
“[Jobs] received a liver transplant because he was the patient with the highest MELD score (Model for End-Stage Liver Disease) of his blood type and, therefore, the sickest patient on the waiting list at the time a donor organ became available. Mr. Jobs is now recovering well and has an excellent prognosis.”
The surgery itself raised many issues. Did Jobs’ wealth and prominence get him special treatment?
Shouldn’t Apple, a publicly traded company, be more transparent on what’s going on with its iconic CEO? Isn’t Jobs health, in fact, material information to be shared? Company boosters maintain that since Jobs handed over day-to-day responsibilities to COO Tim Cook in January, that his health is nobody’s business.
Many beg to differ, especially as Marketwatch’s Therese Poletti points out, Apple continues to slap Jobs’ name in press releases ballyooing various iPhone successes.